Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls
about
Identification of arsenic-binding proteins in human breast cancer cellsComplete absence of M2-pyruvate kinase expression in benign pancreatic ductal epithelium and pancreaticobiliary and duodenal neoplasiaColorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinomaBiomarkers for colorectal cancerPotential of soluble CD26 as a serum marker for colorectal cancer detection.In silico screening, genotyping, molecular dynamics simulation and activity studies of SNPs in pyruvate kinase M2Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening.Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancerExpression of pyruvate kinase M2 in human colorectal cancer and its prognostic valueDiscovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometryCurrent status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy.Upregulation of plasma C9 protein in gastric cancer patients.ITIH3 is a potential biomarker for early detection of gastric cancer.MiR-106b-mediated Mfn2 suppression is critical for PKM2 induced mitochondrial fusion.Review of MicroRNA Proposed Target Genes in Oral Cancer. Part II.Cancer's craving for sugar: an opportunity for clinical exploitation.Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease.Plasma methylated septin 9: a colorectal cancer screening marker.Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice.Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance.Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling.Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients.Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond.Limited Clinical Significance of Dimeric Form of Pyruvate Kinase as a Diagnostic and Prognostic Biomarker in Non-small Cell Lung Cancer.Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamics.[ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients].
P2860
Q30831628-A85CA1B9-721D-46F2-B6A4-E99BDC9A4712Q33503436-C764F92F-5D17-4986-977B-E947CFCA5A26Q33865884-4C455C96-58A2-4021-B9DE-1ADE3DD1F2D7Q34075588-A4E1D51F-2A01-45E1-95B6-C431CB8E0091Q34205596-6EB54E6C-63EC-4F9A-94C9-65F15962A146Q35113393-CE322916-EC47-4BCD-9346-601A4DF8857AQ35175491-9DBD3E8E-9E66-4D00-A695-C5C0F8D70169Q36056889-11EFCF83-BA40-468C-97A2-BAF304B7DDA6Q36166992-6B4FC5BC-5732-4DEA-9A6A-674E0B199319Q36261810-918AA4E9-AE8F-496C-B578-0B6EE7B38F7EQ36713650-A9633437-17E1-4E07-B6D3-CA2F8B5C30CFQ36865592-9BD79715-AB14-4654-9D3D-EDF56824ED18Q37139908-802BFF85-0EAE-4747-B62D-7CB4D6E951BCQ37139950-7EA3AE2A-6EBC-48C2-B53C-62BF433F6E4DQ37382522-0378F017-EF69-4489-9665-866A2D302D93Q37454682-A0F34306-95E1-44B7-95A8-4E8CB3CDC16CQ37470233-1BCAFBB0-13B2-43E8-8D80-10F328BA95CBQ37801547-63560C8A-1C1B-4F6B-80C2-5370AA6FB424Q39093542-216E0D88-AA15-42AA-A11D-2F720EDF859BQ39699461-14145916-A82D-4043-8147-B4861EED8E21Q39828227-67844C24-3D4B-4DBF-BE44-0DDEB937A299Q39984445-E23B8789-0BC8-4A71-A485-4EE2E6D16952Q44176691-EA921BDA-D3FC-45EA-A611-E017DAF7D73CQ46291182-8A30525E-4445-4DAA-B4E0-C734BB0D1EECQ51450937-4B97DB3C-C335-44E2-A3B8-2DE1DB4B6963Q54323425-FE5F529C-A480-41D4-89F6-9873FFF13976Q55437723-46E29502-BF42-4887-80AB-71DD8D0BFD89
P2860
Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@ast
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@en
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@nl
type
label
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@ast
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@en
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@nl
prefLabel
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@ast
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@en
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@nl
P2093
P2860
P356
P1476
Tumor type M2 pyruvate kinase ...... colorectal cancer and controls
@en
P2093
Dao-Da Chen
Guo-Bin Wang
Jian-Ying Chen
P2860
P304
P356
10.3748/WJG.V10.I11.1643
P407
P577
2004-06-01T00:00:00Z